NEW YORK, NY / ACCESSWIRE / January 28, 2016 / The Stock Expert is issuing a report on four stocks to watch. TRXC, PLUG, MNKD and NEOS have been attracting the attention of major investors today. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
TransEnterix, Inc. (NYSE: TRXC) TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. Shares of TransEnterix are trading higher today after announcing today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at the Waldorf Astoria Hotel in New York. The presentation is scheduled to take place at 3:05 pm Eastern Time on Thursday, February 11, 2016. The stock is up over 5% on the announcement and is already trading over three times its average volume.
Sign Up to Receive Hot Small Cap NASDAQ Alerts With Strong Upside Potential. Get Your Free Membership Now.
Plug Power Inc. (NASDAQ: PLUG) Plug Power Inc., an alternative energy technology provider, engages in the design, development, manufacture, and commercialization of fuel cell systems for the industrial off-road markets worldwide. Plug Power is trading off heavier than usual volume after the company exceeded its business goals for 2015. Details of the company's performance in 2015 and its goals for 2016 will be shared on a conference call to be held today at 10:00 am ET. The stock is trading down a little less than a percent after opening the trading day higher.
Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.
MannKind Corp. (NASDAQ: MNKD) MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. Shares of the company are trading lower today after the Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws. This could be terrible news for the struggling biopharmaceutical company that is already trading near its 52 week low of $0.64. Shares are down today 7.61% off steady volume.
Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.
Neos Therapeutics, Inc. (NASDAQ: NEOS) Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Shares of Neos Therapeutics are trading higher today after it announced that FDA approved Adzenys XR-ODT for the treatment of ADHD in patients six years and older. With this approval, Adzenys XR-ODT is the first and only extended-release orally disintegrating tablet for the treatment of ADHD. Shares of the company are up over 30% on the day off extremely heavy volume.
NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.
About TheStockExpert.com
The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.
To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word "STOCKEXPERT".
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.
Contact:
Justin Skibinski
The Stock Expert
info@thestockexpert.com
SOURCE: The Stock Expert
